Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting. | Front Oncol | 2023 | 36761941 | PubTator, text mining | PubMed |
| Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma. | Front Med (Lausanne) | 2023 | 36756176 | PubTator, text mining | PubMed |
| Genetic and phenotypic continuum of HOXA genes: A case with double HOXA9/HOXA13 mutations. | Mol Med Rep | 2023 | 36734258 | PubTator, text mining | PubMed |
| Risk Factors for Respiratory Viral Infections: A Spotlight on Climate Change and Air Pollution. | J Asthma Allergy | 2023 | 36721739 | PubTator, text mining | PubMed |
| Study of the clinicopathological features of soluble PD-L1 in lung cancer patients. | J Rural Med | 2023 | 36700127 | PubTator, text mining | PubMed |
| Apparent Deterioration Law and Shear Failure Mode of Rock-Mortar Interface Based on Topography-Sensing Technology. | Materials (Basel) | 2023 | 36676502 | PubTator, text mining | PubMed |
| Changes in Hox Gene Chromatin Organization during Odontogenic Lineage Specification. | Genes (Basel) | 2023 | 36672939 | PubTator, text mining | PubMed |
| Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma. | Cancer Discov | 2023 | 36669143 | PubTator, text mining | PubMed |
| Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer. | J Transl Med | 2023 | 36639643 | PubTator, text mining | PubMed |
| Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis. | J Neuroimmunol | 2023 | 36621075 | PubTator, text mining | PubMed |
| Galectin-3 interacts with PD-1 and counteracts the PD-1 pathway-driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis. | Scand J Immunol | 2023 | 36537046 | PubTator, text mining | PubMed |
| ANGPTL8 links inflammation and poor differentiation, which are characteristics of malignant renal cell carcinoma. | Cancer Sci | 2023 | 36529524 | PubTator, text mining | PubMed |
| "Stromal cells in prostate cancer pathobiology: friends or foes?" | Br J Cancer | 2023 | 36482187 | PubTator, text mining | PubMed |
| Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer. | J Cancer Res Clin Oncol | 2023 | 36472770 | PubTator, text mining | PubMed |
| Transcriptome analyses in infertile men reveal germ cell-specific expression and splicing patterns. | Life Sci Alliance | 2023 | 36446526 | PubTator, text mining | PubMed |
| FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation. | Blood | 2023 | 36395068 | PubTator, text mining | PubMed |
| Expression and T cell regulatory action of the PD-1 immune checkpoint in the ovary and fallopian tube. | Am J Reprod Immunol | 2023 | 36394352 | PubTator, text mining | PubMed |
| Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis. | Cancer Immunol Immunother | 2023 | 36385210 | PubTator, text mining | PubMed |
| Immune markers and microbial factors are related with periodontitis severity in people with HIV. | Clin Oral Investig | 2023 | 36316604 | PubTator, text mining | PubMed |
| Exploring the Target and Mechanism of Radix Paeoniae Alba on Sjogren's Syndrome. | Comb Chem High Throughput Screen | 2023 | 36017844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=17